scispace - formally typeset
D

Dorte Glintborg

Researcher at Odense University Hospital

Publications -  163
Citations -  4642

Dorte Glintborg is an academic researcher from Odense University Hospital. The author has contributed to research in topics: Polycystic ovary & Insulin resistance. The author has an hindex of 32, co-authored 137 publications receiving 3786 citations. Previous affiliations of Dorte Glintborg include Texas A&M University & Danish Medicines Agency.

Papers
More filters
Journal ArticleDOI

Mitochondrial Respiration Is Decreased in Skeletal Muscle of Patients With Type 2 Diabetes

TL;DR: Evidence is provided for a functional impairment in mitochondrial respiration and increased amount of type 2X fibers in muscle oftype 2 diabetic patients that may contribute to the development of type 1 diabetes in humans with obesity.
Journal ArticleDOI

Reduced Expression of Nuclear-Encoded Genes Involved in Mitochondrial Oxidative Metabolism in Skeletal Muscle of Insulin-Resistant Women With Polycystic Ovary Syndrome

TL;DR: It is demonstrated that impaired insulin-stimulated total, oxidative and nonoxidative glucose disposal in PCOS patients are associated with a consistent downregulation of OXPHOS gene expression using GSEA and GenMAPP analysis, which supports the hypothesis of an early association between insulin resistance and impaired mitochondrial oxidative metabolism.
Journal ArticleDOI

An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome

TL;DR: A comprehensive overview of the pathophysiology and multiple endocrine disturbances of hirsutism and PCOS is given.
Journal ArticleDOI

Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome

TL;DR: The event rate of CVD including hypertension and dyslipidemia was higher in PCOS compared to controls, and the risk of developing CVD must be considered even in young women with PCOS.
Journal ArticleDOI

Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.

TL;DR: The ability of pioglitazone to enhance insulin sensitivity involves improved signaling through Akt and AS160, and the data provide correlative evidence that hyperandrogenism in PCOS may contribute to insulin resistance.